Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
1001
DELISTED
Synovus
SNV
| $14.5M | 0.01% |
707,118
-123,285
| -15% | -$2.38M |
|
1002
Provident Financial Services
PFS
$3.24B
| $14.5M | 0.01% |
1,003,300
-254,988
| -20% | -$3.41M |
|
|
RAVN
1003
DELISTED
Raven Industries Inc
RAVN
| $14.5M | 0.01% |
672,073
+117,173
| +21% | +$2.47M |
|
|
WCC
1004
WESCO International
WCC
$17.8B
| $14.4M | 0.01% |
411,074
+215,474
| +110% | +$6.44M |
|
1005
East-West Bancorp
EWBC
$18.5B
| $14.4M | 0.01% |
398,033
+363,085
| +1,039% | +$12.1M |
|
1006
Varonis Systems
VRNS
$5.26B
| $14.4M | 0.01% |
+488,400
| New | +$12.2M |
|
1007
Bio-Rad Laboratories Class A
BIO
$9.68B
| $14.4M | 0.01% |
31,800
-29,900
| -48% | -$13.2M |
|
|
AMAG
1008
DELISTED
AMAG Pharmaceuticals
AMAG
| $14.3M | 0.01% |
1,873,900
-46,300
| -2% | -$354K |
|
|
SYKE
1009
DELISTED
SYKES Enterprises Inc
SYKE
| $14.3M | 0.01% |
517,770
-66,903
| -11% | -$1.81M |
|
1010
Allstate
ALL
$64.7B
| $14.3M | 0.01% |
147,607
+118,807
| +413% | +$11.7M |
|
1011
John B. Sanfilippo & Son
JBSS
$989M
| $14.3M | 0.01% |
167,500
+64,100
| +62% | +$5.44M |
|
1012
Inspire Medical Systems
INSP
$1.68B
| $14.2M | 0.01% |
163,600
-113,700
| -41% | -$8.74M |
|
1013
Essent Group
ESNT
$6.14B
| $14.2M | 0.01% |
392,000
-639,400
| -62% | -$19.6M |
|
1014
Upwork
UPWK
$1.08B
| $14.2M | 0.01% |
982,400
-893,238
| -48% | -$9.38M |
|
1015
Ryman Hospitality Properties
RHP
$7.82B
| $14.2M | 0.01% |
409,641
+330,300
| +416% | +$11M |
|
1016
1st Source
SRCE
$2.13B
| $14.2M | 0.01% |
398,114
-51,300
| -11% | -$1.7M |
|
|
SASR
1017
DELISTED
Sandy Spring Bancorp Inc
SASR
| $14.2M | 0.01% |
571,341
-139,200
| -20% | -$3.31M |
|
|
CXO
1018
DELISTED
CONCHO RESOURCES INC.
CXO
| $14.1M | 0.01% |
274,642
+222,600
| +428% | +$12.3M |
|
1019
Spok Holdings
SPOK
$230M
| $14.1M | 0.01% |
1,512,493
+60,700
| +4% | +$629K |
|
|
SAIL
1020
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $14.1M | 0.01% |
534,200
-347,300
| -39% | -$7.16M |
|
|
KYNB
1021
Kyntra Bio
KYNB
$28.7M
| $14.1M | 0.01% |
+13,888
| New | +$12.9M |
|
1022
Shake Shack
SHAK
$2.94B
| $14M | 0.01% |
+264,500
| New | +$13.4M |
|
1023
Ducommun
DCO
$3.04B
| $14M | 0.01% |
401,500
-105,200
| -21% | -$3.11M |
|
1024
AutoNation
AN
$6.9B
| $14M | 0.01% |
+372,200
| New | +$13.5M |
|
1025
Universal Technical Institute
UTI
$1.41B
| $14M | 0.01% |
2,009,867
+11,327
| +0.6% | +$74.3K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.